XML 65 R38.htm IDEA: XBRL DOCUMENT v3.25.1
Organization and Description of the Business (Narrative) (Details)
$ / shares in Units, $ in Millions
1 Months Ended 12 Months Ended
Mar. 31, 2024
USD ($)
Dec. 31, 2024
item
$ / shares
Dec. 31, 2023
USD ($)
$ / shares
Common stock, par value (in dollars per share) | $ / shares   $ 0.01 $ 0.01
Innoviva Strategic Opportunities LLC      
Total debt financing | $ $ 90.0   $ 90.0
Number of Directors   3  
Number of Board Directors   8  
Innoviva Strategic Opportunities LLC | Minimum      
Total number of shares (in percentage)   49.50%  
Armata Pharmaceuticals, Inc. | Innoviva Strategic Opportunities LLC      
Outstanding equity (in percent)   69.30%